Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

REGENXBIO (RGNX)

REGENXBIO Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RGNX
DateTimeSourceHeadlineSymbolCompany
30/12/202421:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RGNXREGENXBIO Inc
09/12/202422:12Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RGNXREGENXBIO Inc
09/12/202421:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RGNXREGENXBIO Inc
06/12/202423:29PR Newswire (US)Apollo Global Management and Workday Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600NASDAQ:RGNXREGENXBIO Inc
14/11/202412:05PR Newswire (US)REGENXBIO to Host Webcast Discussing Pivotal Program and First Functional Data from the AFFINITY DUCHENNE® Trial of RGX-202NASDAQ:RGNXREGENXBIO Inc
06/11/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RGNXREGENXBIO Inc
06/11/202421:05PR Newswire (US)REGENXBIO Reports Third Quarter 2024 Financial Results and Recent Operational UpdatesNASDAQ:RGNXREGENXBIO Inc
04/11/202412:05PR Newswire (US)REGENXBIO to Participate in Upcoming Investor ConferencesNASDAQ:RGNXREGENXBIO Inc
30/10/202411:05PR Newswire (US)REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2024 Financial Results and Recent Operational HighlightsNASDAQ:RGNXREGENXBIO Inc
21/10/202411:05PR Newswire (US)REGENXBIO Presents Positive Data from the Phase II Study of Subretinal ABBV-RGX-314 in Patients with Bilateral Wet AMD at AAO 2024NASDAQ:RGNXREGENXBIO Inc
18/10/202411:05PR Newswire (US)REGENXBIO Announces Presentations at the American Academy of Ophthalmology 2024 Annual MeetingNASDAQ:RGNXREGENXBIO Inc
23/09/202420:05PR Newswire (US)REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines ConferenceNASDAQ:RGNXREGENXBIO Inc
18/09/202421:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGNXREGENXBIO Inc
18/09/202421:03Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RGNXREGENXBIO Inc
17/09/202421:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RGNXREGENXBIO Inc
17/09/202411:05PR Newswire (US)REGENXBIO Appoints Mitchell Chan as Chief Financial OfficerNASDAQ:RGNXREGENXBIO Inc
03/09/202412:04PR Newswire (US)REGENXBIO Announces Positive Data from Pivotal Dose Level of RGX-121 Demonstrating Long-Term Systemic EffectNASDAQ:RGNXREGENXBIO Inc
29/08/202420:05PR Newswire (US)REGENXBIO to Participate in Upcoming Investor ConferencesNASDAQ:RGNXREGENXBIO Inc
27/08/202411:05PR Newswire (US)REGENXBIO Announces Presentation at the Society for the Study of Inborn Errors of Metabolism (SSIEM) 2024 Annual SymposiumNASDAQ:RGNXREGENXBIO Inc
12/08/202420:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGNXREGENXBIO Inc
08/08/202411:05PR Newswire (US)REGENXBIO to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual ConferenceNASDAQ:RGNXREGENXBIO Inc
05/08/202422:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGNXREGENXBIO Inc
05/08/202422:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGNXREGENXBIO Inc
01/08/202420:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RGNXREGENXBIO Inc
01/08/202420:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RGNXREGENXBIO Inc
01/08/202420:05PR Newswire (US)REGENXBIO Reports Second Quarter 2024 Financial Results and Recent Operational HighlightsNASDAQ:RGNXREGENXBIO Inc
01/08/202411:03PR Newswire (US)REGENXBIO ANNOUNCES NEW POSITIVE DATA FROM AFFINITY DUCHENNE® TRIAL OF RGX-202NASDAQ:RGNXREGENXBIO Inc
26/07/202421:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGNXREGENXBIO Inc
25/07/202411:05PR Newswire (US)REGENXBIO to Host Conference Call on August 1 to Discuss Second Quarter 2024 Financial Results and Recent Operational HighlightsNASDAQ:RGNXREGENXBIO Inc
18/07/202421:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RGNXREGENXBIO Inc
 Showing the most relevant articles for your search:NASDAQ:RGNX

Your Recent History

Delayed Upgrade Clock